[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100470940":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":26,"locations":37,"responsibleParty":90,"collaborators":94,"id":105,"slug":106,"hasResults":107,"nctId":108,"briefTitle":109,"officialTitle":110,"acronym":31,"eligibilityCriteria":111,"healthyVolunteers":107,"sex":112,"minAge":113,"maxAge":114,"enrollmentInfo":115,"targetDuration":31,"studyType":118,"phases":119,"briefSummary":121,"conditions":122,"keywords":124,"overallStatus":40,"whyStopped":31,"lastUpdateSubmitDate":128,"lastUpdatePostDateStruct":129,"startDateStruct":132,"completionDateStruct":134,"leadSponsor":136,"locationsCount":137},{"fullName":5,"class":6},"Nationwide Children's Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Experimental","EXPERIMENTAL","This is a one-arm study and the group of subjects are all experimental and will receive drug.",[13],"Drug: Prednisolone",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","Prednisolone","Liquid, 5mg\u002Fkg per week, for one year",[9],[21],"Corticosteroid",[23],{"name":24,"affiliation":5,"role":25},"Anne Connolly, MD","PRINCIPAL_INVESTIGATOR",[27,33],{"name":28,"role":29,"phone":30,"phoneExt":31,"email":32},"Sara Marshall","CONTACT","614-355-3508",null,"sara.adamczak@nationwidechildrens.org",{"name":34,"role":29,"phone":35,"phoneExt":31,"email":36},"Kevin Warf","614-355-2765","kevin.warf@nationwidechildrens.org",[38,52,62,75],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":31},"Lurie Children's Hospital of Chicago","RECRUITING","Chicago","Illinois","60611","United States","US",{"type":47,"coordinates":48},"Point",[49,50],-87.65005,41.85003,{"lat":50,"lon":49},{"facility":53,"status":40,"city":54,"state":55,"zip":56,"country":44,"countryCode":45,"cosmosGeoPoint":57,"geoPoint":61,"contacts":31},"University of Cincinnati","Cincinnati","Ohio","45220",{"type":47,"coordinates":58},[59,60],-84.51439,39.12711,{"lat":60,"lon":59},{"facility":5,"status":40,"city":63,"state":55,"zip":64,"country":44,"countryCode":45,"cosmosGeoPoint":65,"geoPoint":69,"contacts":70},"Columbus","43205",{"type":47,"coordinates":66},[67,68],-82.99879,39.96118,{"lat":68,"lon":67},[71,74],{"name":72,"role":29,"phone":73,"phoneExt":31,"email":36},"Kevin Warf, BS","(614) 355-2765",{"name":24,"role":25,"phone":31,"phoneExt":31,"email":31},{"facility":76,"status":40,"city":77,"state":78,"zip":79,"country":44,"countryCode":45,"cosmosGeoPoint":80,"geoPoint":84,"contacts":85},"University of Texas Southwestern","Dallas","Texas","75235",{"type":47,"coordinates":81},[82,83],-96.80667,32.78306,{"lat":83,"lon":82},[86],{"name":87,"role":29,"phone":88,"phoneExt":31,"email":89},"Shahera Ranjha, MS","214-456-5959","shahera.ranjha@utsouthwestern.edu",{"type":91,"investigatorFullName":92,"investigatorTitle":93,"investigatorAffiliation":5,"oldNameTitle":31,"oldOrganization":31},"SPONSOR_INVESTIGATOR","Anne M. Connolly","Chief of Division of Neurology",[95,97,99,101,103],{"name":96,"class":6},"Children's Hospital Medical Center, Cincinnati",{"name":98,"class":6},"Muscular Dystrophy Association",{"name":100,"class":6},"University of Texas",{"name":102,"class":6},"Virginia Commonwealth University",{"name":104,"class":6},"Ann & Robert H Lurie Children's Hospital of Chicago","100470940","phase-4-once-weekly-infant-corticosteroid-trial-for-dmd-100470940",false,"NCT05412394","Once Weekly Infant Corticosteroid Trial for DMD","Phase-2 Trial of 5mg\u002Fkg\u002FWeek Prednisolone in Young Boys With DMD","Inclusion Criteria:\n\n* Subjects ages 1 month through 30 months\n* Weakness consistent with Duchenne on exam, creatine kinase ≥ 20 times the upper limit of normal, and genetic mutation known to be causative for DMD.\n\nExclusion Criteria:\n\n* Prior treatment with Glucocorticosteroids","MALE","1 Month","30 Months",{"count":116,"type":117},26,"ESTIMATED","INTERVENTIONAL",[120],"PHASE4","The hypothesis tested here is that a lower dose of intermittent oral corticosteroids (5mg\u002Fkg\u002Fweek) will be equally effective to the 10mg\u002Fkg\u002Fweek dose.",[123],"Duchenne Muscular Dystrophy",[123,125,126,127],"DMD","Steroid","Muscular Dystrophy","2025-08-08",{"date":130,"type":131},"2025-08-13","ACTUAL",{"date":133,"type":131},"2021-04-30",{"date":135,"type":117},"2026-12",{"name":92,"class":6},4]